June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Epigenetic modifications and regulation of matrix metalloproteinase-9 in the development of diabetic retinopathy
Author Affiliations & Notes
  • Arul Joseph Duraisamy
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Renu A Kowluru
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Arul Joseph Duraisamy, None; Renu Kowluru, None
  • Footnotes
    Support  R01-EY014370, R01-EY017313, and R01-EY022230
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1846. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Arul Joseph Duraisamy, Renu A Kowluru; Epigenetic modifications and regulation of matrix metalloproteinase-9 in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1846.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Matrix metalloproteinase-9 (MMP-9) is activated in the retina in diabetes, and translocates into the mitochondria, damaging their membranes and accelerating capillary cell apoptosis. MMP-9 expression is regulated by DNA/histone modifications in the promoter sequence that controls activator protein -1 (AP-1) transcription factor binding. Dynamic balance between methyltransferase, Ezh2, and demethylase, KDM6B, regulates methyl modifications at the lysine 27 of histone 3 (H3K27), which, in di- and tri-methylated form, represses gene expression, but in mono-methylated form, it could activate the transcription. The present study aims to elucidate the role of H3K27 methylation in retinal MMP-9 transcriptional activation in diabetes.

Methods : Retinal microvessels were prepared by osmotic shock method from rats maintained diabetic (streptozotocin-induced) for 2 months. Lysine methylation of H3K27- (me1, me2 and me3), and also the recruitments of Ezh2 and KDM6B, at AP-1 region of MMP-9 promoter were analyzed in the crosslinked retinal microvessels by chromatin immunoprecipitation using antibodies specific for H3K27me1, H3K27me2, H3K27me3, Ezh2 and KDM6B.

Results : Compared to the retinal microvessels from age-matched normal rats, microvessels from diabetic rats had increased H3K27me2 and H3K27me3 at the AP-1 binding region of the MMP-9 promoter, but H3K27me1 levels were similar in these two groups. Interestingly, at the same AP-1 region, the binding of Ezh2, and that of KDM6B, were also elevated.

Conclusions : Although diabetes increases the binding of demethylase, KDM6B, at AP-1 region of the MMP-9 promoter, concomitant increased binding of methyltransferase, Ezh2, at same site, maintains higher levels of H3K27me3/me2. Thus, demethylation of H3K27me2/me3 by KDM6B might not be efficient, and instead, diabetes could also be facilitating recruitment of other histone modifying enzymes at the MMP-9 promoter to increase its transcription.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×